| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| 200,000 SHARES OF NAUTILUS BIOTECHNOLOGY INC. COMMON STOCK | AT COST | 1,026,000 | 632,900 |
| MORGAN STANLEY - EXCHANGE TRADED AND CLOSE- END FUNDS | AT COST | 19,691 | 20,025 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| PROFESSIONAL FEES | 9,190 | 0 | 9,190 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| LEGAL FEES | 3,607 | 0 | 3,607 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXCISE TAXES | 143 | 143 | 0 |